Inovalon is a leading technology company that combines advanced cloud-based data analytics, and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. Inovalon’s unique achievement of value is delivered through the effective progression of Turning Data into Insight, and Insight into Action®. Large proprietary datasets, advanced integration technologies, sophisticated predictive analytics, data-driven intervention platforms, and deep subject matter expertise deliver a seamless, end-to-end capability that brings the benefits of big data and large-scale analytics to the point of care. Driven by data, Inovalon uniquely identifies gaps in care, quality, data integrity, and financial performance – while bringing to bear the unique capabilities to resolve them. Inovalon provides technology that supports hundreds of healthcare organizations in 98.4% of U.S. counties and Puerto Rico with cloud-based analytical and data-driven intervention platforms that are informed by data pertaining to more than 804,000 physicians, 306,000 clinical facilities, and more than 137 million Americans. Through these capabilities, and those of its subsidiary Avalere Health, which offers data-driven advisory services and business intelligence to more than 200 pharmaceutical and life sciences enterprises, Inovalon is able to drive high-value impact, improving quality and economics for health plans, ACOs, hospitals, physicians, consumers and pharma/life-sciences researchers.
2015 Annual Report, 10-K and 2016 Proxy Statement
To view the 2015 Annual Report & 10-K please click here.
To view the 2016 Proxy Statement please click here.
Inovalon To Acquire Creehan & Company
To read the Transaction Brief click here.